From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy
{{output}}
Background: New indications for existing medicines are increasing over time. In most countries, drug pricing and reimbursement conditions are renegotiated every time a new indication is approved. There is a growing interest in th... ...
